Hepatitis C Vaccine Development
Hepatitis C virus-host interactions examined
Published in Vaccine Weekly, October 12th, 2005
"The human suffering exacted by the hepatitis C virus is enormous. Hundreds of thousands of people die each year from liver failure and cancer caused by this infection. There is no vaccine, and the available antiviral drugs are toxic, expensive and only partly effective," scientists writing in the journal Nature report.
"Progress has been hindered by the absence of cell culture and small-animal models of the infection," said Francis V. Chisari at the Scripps Research Institute. "Nonetheless, recent advances have yielded several promising new antiviral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-10-12)
More Articles from Vaccine Weekly
- Myeloma Vaccine Development
Tumor antigen immunization of stem cell transplant donors reported - Rotavirus Vaccine Development
Human rotavirus-bovine rotavirus reassortant vaccine developed - Rotavirus Vaccine Development
Pentavalent rotavirus vaccine against gastroenteritis developed - Vaccine Development
Killed but active microbes proposed for new vaccine paradigm - Anthrax Vaccine Development
Antibody patterns in anthrax vaccinees reported - Apoptosis
Isothiocyanates induced cell apoptosis - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
